Molecular epidemiology of HIV-1 genetic forms and its significance for vaccine development and therapy.
about
Virus maturation as a new HIV-1 therapeutic targetClade, Country and Region-specific HIV-1 Vaccines: Are they necessary?HIV/AIDS vaccines for Africa: scientific opportunities, challenges and strategiesViral quasispecies evolutionEvaluating association and transmission of eight inflammatory genes with Viliuisk encephalomyelitis susceptibilityDeep sequencing of HIV-1 near full-length proviral genomes identifies high rates of BF1 recombinants including two novel circulating recombinant forms (CRF) 70_BF1 and a disseminating 71_BF1 among blood donors in Pernambuco, BrazilDNA vaccines against human immunodeficiency virus type 1.Molecular epidemiology of HIV in two highly endemic areas of northeastern South Africa.Identification of an HIV-1 BG Intersubtype Recombinant Form (CRF73_BG), Partially Related to CRF14_BG, Which Is Circulating in Portugal and SpainUse of phylogenetics in the molecular epidemiology and evolutionary studies of viral infections.Genomic Diversity of Human Immunodeficiency Viruses.The origin and evolutionary history of HIV-1 subtype C in SenegalThe HIV-1 pandemic: does the selective sweep in chimpanzees mirror humankind's future?Enhanced detection of viral diversity using partial and near full-length genomes of human immunodeficiency virus Type 1 provirus deep sequencing data from recently infected donors at four blood centers in Brazil.Use of sequence data generated in the Bayer Tru Gene genotyping assay to recognize and characterize non-subtype-b human immunodeficiency virus type 1 strainsGenetic analysis of HIV-1 subtypes in Nairobi, Kenya.HIV-1 subtype and viral tropism determination for evaluating antiretroviral therapy options: an analysis of archived Kenyan blood samplesCompetition-colonization dynamics in an RNA virus.Genetic characterization and antiretroviral resistance mutations among treatment-naive HIV-infected individuals in Jiaxing, China.Impact of HIV-1 viral subtype on disease progression and response to antiretroviral therapy.Characterization of HIV-1 CRF90_BF1 and putative novel CRFs_BF1 in Central West, North and Northeast Brazilian regions.T-cell immune responses against Env from CRF12_BF and subtype B HIV-1 show high clade-specificity that can be overridden by multiclade immunizationsIncreased immunogenicity of HIV-1 p24 and gp120 following immunization with gp120/p24 fusion protein vaccine expressing alpha-gal epitopesHIV dynamics with multiple infections of target cells.More accurate recombination prediction in HIV-1 using a robust decoding algorithm for HMMs.Patterns of Human Immunodeficiency Virus type 1 recombination ex vivo provide evidence for coadaptation of distant sites, resulting in purifying selection for intersubtype recombinants during replication.Immunogenicity of ALVAC-HIV vCP1521 in infants of HIV-1-infected women in Uganda (HPTN 027): the first pediatric HIV vaccine trial in Africa.Molecular diversity of HIV-1 among people who inject drugs in Kuala Lumpur, Malaysia: massive expansion of circulating recombinant form (CRF) 33_01B and emergence of multiple unique recombinant clusters.Multiple barriers to recombination between divergent HIV-1 variants revealed by a dual-marker recombination assayA mechanistic understanding of allosteric immune escape pathways in the HIV-1 envelope glycoprotein.Evaluation of the clinical sensitivities of three viral load assays with plasma samples from a pediatric population predominantly infected with human immunodeficiency virus type 1 subtype G and BG recombinant forms.Mechanisms and factors that influence high frequency retroviral recombinationThe epidemiology and clinical correlates of HIV-1 co-receptor tropism in non-subtype B infections from India, Uganda and South Africa.Phylogeny and Phylogeography of a Recent HIV-1 Subtype F Outbreak among Men Who Have Sex with Men in Spain Deriving from a Cluster with a Wide Geographic Circulation in Western EuropeHIV-1 genetic diversity in antenatal cohort, Canada.The HIV Epidemic: High-Income Countries.Variable effect of co-infection on the HIV infectivity: within-host dynamics and epidemiological significance.Ultra-Deep Sequencing of HIV-1 near Full-Length and Partial Proviral Genomes Reveals High Genetic Diversity among Brazilian Blood Donors.Characterization of circulating HIV type 1 env genes in plasma of two antiretroviral-naive slow progressing patients with broad neutralizing antibody response with evidence of recombination.Safety and Immunogenicity of the MRKAd5 gag HIV Type 1 Vaccine in a Worldwide Phase 1 Study of Healthy Adults
P2860
Q24642446-F9C6EDBA-272A-4F75-B6F2-51B7505C08D4Q24803275-ECB1492D-9AE5-4D0C-B890-7E2F12B53ACBQ26799624-B675C669-AAB4-45AF-9BB1-F5E51DBD8689Q27013917-8FE5E6ED-24F3-488F-9D93-3D30C708F2D1Q28265363-3A80B532-1FE1-4355-8111-0E40A6F2110CQ28544988-F30DBF50-D181-411B-96C9-2C7A6E9FD5EEQ30342130-A1893C7A-9957-4789-AB03-937C8E8EC0F4Q30357556-41C56448-C67C-4DBC-965B-211EB47CFC19Q30384693-D253400D-E5F0-468C-B6FB-ECA8968FB3FBQ30387664-689AA7E3-1DD5-4724-A404-6F3BC04C325DQ30390449-2DA8BF24-0A1A-483D-A33A-28577ACD1C4EQ30414915-02DCE938-DC1C-43BE-AC56-D34187F4534CQ30431054-724F6800-2770-4059-93A1-9F28B9420CBFQ30870822-82114960-C6C4-4BBB-A47F-B9A49DF806E1Q31009699-38768D77-02E7-4619-A4C4-76458D60D3C4Q33368620-42CEE48F-1F78-4ED8-A9E4-2CD2F696C85FQ33521125-72AACCB2-6F92-496B-9241-3825435B89AAQ33524705-AC44F19D-A0EF-40D2-A123-EF89AECC5E13Q33566910-879CE667-4587-4213-BB0B-A8B4B8527AECQ33683115-D7AED316-A7F2-4F56-8D88-A55873D13960Q33811732-CFB7FA13-79BB-4614-9698-D192677F7E98Q33833624-056B42D4-A741-4159-832E-E8CEE201DB6BQ33837215-C8365A79-BA68-4B67-96CA-25AA9456CA2FQ33852032-05EDB12B-C3A3-4CCC-A838-018CEA1EA46CQ33903458-E0219996-AFB4-4E09-BFDF-423912C020CCQ33964088-25A108A5-C20A-4986-88B9-6AB03A4902FAQ34229329-FFCFC529-C416-4267-A30D-7C1EB0E57068Q34717345-9398A9C1-5407-4168-B473-497BEC594D72Q34731376-8A703E7A-3492-443D-9F57-9450D2D8E54FQ34733504-EBD6BD60-D018-46E0-BB17-6C2EBADBAE13Q35156353-67A63FBE-4948-43AB-951F-55EAAD8823AFQ35276750-9E856C2D-67B1-4465-AE7F-61081E3A40FFQ35818419-28E1ACD6-ABC1-4682-B02C-4C4151049254Q35850067-D57767C9-BF51-46DC-ACC9-10996F035475Q35873428-D295FBAF-694F-43B9-9ACE-032642B8DC20Q35902684-3C558CA5-44D5-4CD7-B151-A7C21ABB9866Q35914310-A7099CE9-F414-4507-BB4D-83CF08D60856Q35975154-DE8A2A44-C79F-4729-8B32-AC3DD89C705DQ36050129-23CE5803-55D8-4D6C-AFB0-DFD365F90403Q36172965-564FF01E-F536-4BE4-9505-1BFEC0AB32BE
P2860
Molecular epidemiology of HIV-1 genetic forms and its significance for vaccine development and therapy.
description
2002 nî lūn-bûn
@nan
2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
name
Molecular epidemiology of HIV- ...... ccine development and therapy.
@ast
Molecular epidemiology of HIV- ...... ccine development and therapy.
@en
type
label
Molecular epidemiology of HIV- ...... ccine development and therapy.
@ast
Molecular epidemiology of HIV- ...... ccine development and therapy.
@en
prefLabel
Molecular epidemiology of HIV- ...... ccine development and therapy.
@ast
Molecular epidemiology of HIV- ...... ccine development and therapy.
@en
P2093
P1476
Molecular epidemiology of HIV- ...... ccine development and therapy.
@en
P2093
Lucía Pérez-Alvarez
Michael M Thomson
Rafael Nájera
P304
P356
10.1016/S1473-3099(02)00343-2
P577
2002-08-01T00:00:00Z